{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:21:38Z","timestamp":1786972898497,"version":"build-2736575974"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a common neurodegenerative disease in middle-aged and elderly people, and there is less research on the relationship between immunity and PD. In this study, the protein-protein interaction networks (PPI) data, 2747 human immune-related genes (HIRGs), 2078 PD-related genes (PDRGs), and PD-related datasets (GSE49036 and GSE20292) were downloaded from the Human Protein Reference Database (HPRD), Amigo 2, DisGeNET, and Gene Expression Omnibus (GEO) databases, respectively. An immune- or PD-directed neighbor co-expressed network construction (IOPDNC) was drawn based on the GSE49036 dataset and HPRD database. Furthermore, a PD-directed neighbor co-expressed network was constructed. Modular clustering analysis was performed on the genes of the gene interaction network obtained in the first step to obtain the central core genes using the GraphWeb online website. The modules with the top 5 functional scores and the number of core genes greater than six were selected as PD-related gene modules. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses of different module genes were performed. The single sample Gene Set Enrichment Analysis (ssGSEA) algorithm was used to calculate the immune cell infiltration of the PD and the normal samples. The quantitative Reverse Transcription Polymerase Chain Reaction (qRT-PCR) was performed to investigate the expression of module genes. An IOPDNC and PD-directed neighbor co-expressed network (PDNC network) were constructed. Furthermore, a total of 5 immune-PD modules were identified which could distinguish between PD and normal samples, and these module genes were strongly related to PD in protein interaction level or gene expression level. In addition, functional analysis indicated that module genes were involved in various neurodegenerative diseases, such as Alzheimer disease, Huntington disease, Parkinson disease, and Long-term depression. In addition, the genes of the 6 modules were significantly associated with these 4 differential immune cells (aDC cells, eosinophils, neutrophils, and Th2 cells). Finally, the result of qRT-PCR manifested that the expression of 6 module genes was significantly higher in normal samples than in PD samples. In our study, the immune-related genes were found to be strongly related to PD and might play key roles in PD.<\/jats:p>","DOI":"10.3389\/fgene.2023.1090382","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T05:01:51Z","timestamp":1673931711000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Identification of immune signatures in Parkinson\u2019s disease based on co-expression networks"],"prefix":"10.3389","volume":"14","author":[{"given":"Xiaolin","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s12035-021-02569-6","article-title":"NME1 protects against neurotoxin-\u03b1-synuclein- and LRRK2-induced neurite degeneration in cell models of Parkinson's disease","volume":"59","author":"Anantha","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1007\/s12035-020-02201-z","article-title":"Pivotal role of Fyn kinase in Parkinson's disease and levodopa-induced dyskinesia: A novel therapeutic target?","volume":"58","author":"Angelopoulou","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1038\/ncomms4633","article-title":"MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration","volume":"5","author":"Cebri\u00e1n","year":"2014","journal-title":"Nat. Commun."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e1007095","DOI":"10.1371\/journal.pgen.1007095","article-title":"A MIG-15\/JNK-1 MAP kinase cascade opposes RPM-1 signaling in synapse formation and learning","volume":"13","author":"Crawley","year":"2017","journal-title":"PLoS Genet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fnana.2018.00113","article-title":"Advances in Parkinson's disease: 200 Years later","volume":"12","author":"Del Rey","year":"2018","journal-title":"Front. Neuroanat."},{"key":"B6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.expneurol.2009.03.002","article-title":"Anti-melanin antibodies are increased in sera in Parkinson's disease","volume":"217","author":"Double","year":"2009","journal-title":"Exp. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1073\/pnas.1909110117","article-title":"NK cells clear \u03b1-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of \u03b1-synucleinopathy","volume":"117","author":"Earls","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B8","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00702-020-02167-1","article-title":"Parkinson's disease treatment: Past, present, and future","volume":"127","author":"Elsworth","year":"2020","journal-title":"J. Neural Transm. (Vienna)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e2020858118","DOI":"10.1073\/pnas.2020858118","article-title":"Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder","volume":"118","author":"Farmen","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"992505","DOI":"10.3389\/fimmu.2022.992505","article-title":"Single-cell RNA sequencing of CSF reveals neuroprotective RAC1+ NK cells in Parkinson's disease","volume":"13","author":"Guan","year":"2022","journal-title":"Front. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1007\/s12035-021-02518-3","article-title":"Fyn kinase activity and its role in neurodegenerative disease pathology: A potential universal target?","volume":"58","author":"Guglietti","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1021\/acschemneuro.7b00063","article-title":"Immunochemical detection of \u03b1-synuclein autoantibodies in Parkinson's disease: Correlation between plasma and cerebrospinal fluid levels","volume":"8","author":"Horvath","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.nbd.2018.11.024","article-title":"Naturally occurring autoantibodies against \u03b1-synuclein rescues memory and motor deficits and attenuates \u03b1-synuclein pathology in mouse model of Parkinson's disease","volume":"124","author":"Huang","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B14","first-page":"67","article-title":"p38 MAPK and PI3K\/AKT signalling cascades inParkinson's disease","volume":"4","author":"Jha","year":"2015","journal-title":"Int. J. Mol. Cell Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrneurol.2015.249","article-title":"Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD","volume":"12","author":"Kalia","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1016\/s0021-9258(19)85886-6","article-title":"Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover","volume":"255","author":"Kishimoto","year":"1980","journal-title":"J. Biol. Chem."},{"key":"B17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/mds.28411","article-title":"Genetic and environmental factors in Parkinson's disease converge on immune function and inflammation","volume":"36","author":"Kline","year":"2021","journal-title":"Mov. Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1038\/s41467-019-12538-2","article-title":"Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson's disease","volume":"10","author":"Krashia","year":"2019","journal-title":"Nat. Commun."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1093\/brain\/awy211","article-title":"Can neuroimaging predict dementia in Parkinson\u2019s disease?","volume":"141","author":"Lanskey","year":"2018","journal-title":"Brain"},{"key":"B20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41531-018-0058-0","article-title":"Prevalence of Parkinson's disease across north America","volume":"4","author":"Marras","year":"2018","journal-title":"NPJ Park. Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s00018-011-0850-z","article-title":"Transgenic expression and activation of PGC-1\u03b1 protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease","volume":"69","author":"Mud\u00f2","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson's disease: Mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1080\/21691401.2019.1636805","article-title":"Long noncoding RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100\/ATG10 axis and PI3K\/Akt\/mTOR pathway activation","volume":"47","author":"Peng","year":"2019","journal-title":"Artif. Cells Nanomed Biotechnol."},{"key":"B24","article-title":"Grin1-Related neurodevelopmental disorder [M]\/\/Adam M P","author":"Platzer","year":"1993"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3109\/00207454.2014.986673","article-title":"Identification of potential drugs for Parkinson's disease based on a sub-pathway method","volume":"126","author":"Sun","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1001\/jama.2012.4829","article-title":"Treatment of Parkinson disease: A 64-year-old man with motor complications of advanced Parkinson disease","volume":"307","author":"Tarsy","year":"2012","journal-title":"Jama"},{"key":"B28","volume-title":"ggplot2: Elegant graphics for data analysis","author":"Villanueva","year":"2019"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: A class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.neulet.2010.04.063","article-title":"Association analysis of GRIN1 and GRIN2B polymorphisms and Parkinson's disease in a hospital-based case-control study","volume":"478","author":"Wu","year":"2010","journal-title":"Neurosci. Lett."},{"key":"B31","doi-asserted-by":"publisher","first-page":"100141","DOI":"10.1016\/j.xinn.2021.100141","article-title":"clusterProfiler 4.0: A universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innov. (Camb)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e18513","DOI":"10.1371\/journal.pone.0018513","article-title":"\u03b1-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients","volume":"6","author":"Yanamandra","year":"2011","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"101978","DOI":"10.1016\/j.redox.2021.101978","article-title":"Regulation of metastasis suppressor NME1 by a key metabolic cofactor coenzyme A","volume":"44","author":"Yu","year":"2021","journal-title":"Redox Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1034\/j.1600-0404.2002.01240.x","article-title":"Anti-GM1 ganglioside antibodies in Parkinson's disease","volume":"106","author":"Zappia","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"B35","doi-asserted-by":"publisher","first-page":"10881","DOI":"10.1007\/s11033-012-1985-1","article-title":"Identification of key pathways and transcription factors related to Parkinson disease in genome wide","volume":"39","author":"Zhang","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.bbr.2013.07.036","article-title":"PKC-epsilon activation is required for recognition memory in the rat","volume":"253","author":"Zisopoulou","year":"2013","journal-title":"Behav. Brain Res."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1090382\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T05:01:57Z","timestamp":1673931717000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2023.1090382\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":36,"alternative-id":["10.3389\/fgene.2023.1090382"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2023.1090382","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"article-number":"1090382"}}